Pathway Medical Technologies, Inc. Series D $42.5M

Posted in I - Series D, Q - 2Q09, R - NORTH WEST, X - Device (Vascular), X - PAD, XX - WA

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $42.5M Series D financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners, Giza Venture Capital and WRF Capital.

Jun

2009

Proteon Therapeutics, Inc.: Series B $12M

Posted in I - Series B, Q - 2Q09, R - NORTH EAST, X - Hemodialysis, X - PAD, X - Renal, X - Vascular, XX - MA

Proteon Therapeutics (Waltham, MA) a clinical-stage biopharmaceutical company focused on a recombinant human elastase designed to improve arteriovenous fistula surgery outcomes in patients requiring chronic hemodialysis, closed on $12M, bringing the total Series B financing to $50M. Participants include Bessemer Venture Partners, Devon Park Bioventures, MPM Bio, Vectis Healthcare & Life Science Fund, TVM Capital, [...]

Nov

2008

Pathway Medical Technologies, Inc.: Series B $24.5M

Posted in I - Series B, Q - 2Q08, R - NORTH EAST, X - Device (Vascular), X - PAD

Pathway Medical Technologies (Kirkland, WA) development-stage medical company focused on peripheral-arterial disease, closed a $24.5M Series B financing. Participants include HLM Venture Partners, Latterell Venture Partners, Oxford Bioscience Partners, Forbion Capital Partners and Giza Venture Capital.

to top of page...